(Q53248118)

English

Initial experience with temsirolimus in 2nd-, 3rd- and 4th-line therapy for metastatic renal cell cancer: good clinical response.

scientific article published on 25 January 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21266794

Initial experience with temsirolimus in 2nd-, 3rd- and 4th-line therapy for metastatic renal cell cancer: good clinical response. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21266794

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21266794

Markus Hohenfellner

7

object named as

Markus Hohenfellner

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

Boris Hadaschik

object named as

Boris Hadaschik

6

0 references

Sascha Pahernik

5

object named as

Sascha Pahernik

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

Gencay Hatiboglu

3

object named as

Gencay Hatiboglu

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21266794

4

object named as

Nina Wagener

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21266794

author name string

Timur Hasan Kuru

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21266794

publication date

25 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21266794

Urologia Internationalis

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21266794

86

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21266794

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21266794

256-260

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21266794

EAU guidelines on renal cell carcinoma: the 2010 update

1 reference

https://api.crossref.org/works/10.1159%2F000322545

21 January 2018

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000322545

21 January 2018

Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features

1 reference

https://api.crossref.org/works/10.1159%2F000322545

21 January 2018

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000322545

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1159%2F000322545

21 January 2018

Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapy

1 reference

https://api.crossref.org/works/10.1159%2F000322545

21 January 2018

Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1159%2F000322545

21 January 2018

Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus

1 reference

https://api.crossref.org/works/10.1159%2F000322545

21 January 2018

Emergent toxicities associated with the use of mTOR inhibitors in patients with advanced renal carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000322545

21 January 2018

Identifiers

10.1159/000322545

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21266794

release_xzq2ftkxwnbdtco6j6tdr5svgi

1 reference

https://api.fatcat.wiki/v0/release/xzq2ftkxwnbdtco6j6tdr5svgi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21266794

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53248118&oldid=1857396294"